2026 Plan for Issuance of A-Shares to Specific Targets (Revised Draft)

[Image: Tianshan logo]

Xinjiang Tianshan Animal Husbandry Bio-Engineering Co., Ltd.

(No. 1, Guangming South Road, Changji High-tech Zone, Changji Prefecture, Xinjiang)

2026 Plan for Issuance of A-Shares to Specific Targets (Revised Draft)

June 2026

Issuer Statement

1. The Company and all members of the Board of Directors guarantee that the contents of this plan are true, accurate, and complete, and contain no false records, misleading statements, or major omissions. They fulfill their commitments in accordance with the principle of good faith and bear corresponding legal liabilities.

2. This plan is prepared in accordance with the requirements of the Securities Law of the People's Republic of China, the Administrative Measures for the Registration of Securities Issuance by Listed Companies, and other laws, regulations, and normative documents.

3. Upon completion of this issuance of shares to specific targets, the Company shall be solely responsible for changes in its operations and earnings; investors shall be solely responsible for investment risks arising from this issuance.

4. This plan is an explanation by the Board of Directors regarding this issuance of shares to specific targets; any statement to the contrary is a false statement.

5. Investors with any questions should consult their stock brokers, lawyers, professional accountants, or other professional advisors.

6. The matters described in this plan do not represent a substantive judgment, confirmation, or approval by the approval authorities regarding the matters related to this issuance. The effectiveness and completion of the matters described herein are still subject to review and approval by the Shenzhen Stock Exchange and registration by the China Securities Regulatory Commission.

Special Notice

1. The matters related to this issuance of shares to specific targets have been deliberated and approved by the third meeting of the sixth Board of Directors, the 2025 General Meeting of Shareholders, and the fifth meeting of the sixth Board of Directors. They are subject to review by the Shenzhen Stock Exchange and registration by the China Securities Regulatory Commission before implementation.

2. The targets of this issuance are Mr. Chen Mingyi and Xiamen Shede. Mr. Chen Mingyi and Xiamen Shede have respectively signed the "Conditional Share Subscription Agreement" and the "Supplementary Agreement to the Conditional Share Subscription Agreement" with the Company, intending to subscribe for the shares issued by the Company to specific targets in cash. This issuance constitutes a related-party transaction. When the Board of Directors deliberated on the relevant proposals, the related directors abstained from voting; when the General Meeting of Shareholders deliberated on the relevant proposals, the related shareholders abstained from voting.

3. The pricing benchmark date for this issuance is the first day of the issuance period. The issue price shall not be lower than 80% of the average trading price of the Company's shares for the 20 trading days preceding the pricing benchmark date (Average trading price for the 20 trading days preceding the pricing benchmark date = Total trading volume of the Company's shares for the 20 trading days preceding the pricing benchmark date / Total trading amount of the Company's shares for the 20 trading days preceding the pricing benchmark date).

If the Company's shares are subject to ex-rights or ex-dividend matters such as dividend distribution, bonus shares, or capitalization of capital reserves between the pricing benchmark date and the issuance date, the issue price will be adjusted accordingly. If regulatory agencies such as the China Securities Regulatory Commission or the Shenzhen Stock Exchange subsequently revise the regulations or issue new regulatory opinions regarding the pricing benchmark date, pricing principles, and issue price for the issuance of shares to specific targets, the pricing benchmark date, pricing principles, and issue price shall be determined in accordance with the revised regulations or the latest regulatory opinions.